BETA BIONICS INC (BBNX:NASDAQ)
$12.79 0.67 (5.5281%)
Analysed BETA BIONICS INC (BBNX:NASDAQ) News Sources
Beta Bionics Inc (BBNX) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Operational ...
22-04-2026
yahoo.com
Beta Bionics, Inc. Q1 2026 Earnings Call Summary
22-04-2026
moby.co
Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
23-04-2026
yahoo.com
Beta Bionics to Present at the Bank of America Securities Health Care Conference
27-04-2026
yahoo.com
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation
12-05-2026
yahoo.com
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
13-05-2026
marketbeat.com
Robert Bruce's Strategic Moves: A Closer Look at Beta Bionics Inc's Impactful Addition
14-05-2026
yahoo.com
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
15-05-2026
fool.com
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
21-05-2026
yahoo.com
Beta Bionics to launch its first insulin patch pump to compete with Insulet
26-05-2026
medtechdive.com
What is the current price of BETA BIONICS INC (BBNX:NASDAQ)?
The current price of BETA BIONICS INC (BBNX:NASDAQ) is $12.79.
BETA BIONICS INC (BBNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BETA BIONICS INC (BBNX:NASDAQ) since the previous trading day is $0.67.
BETA BIONICS INC (BBNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BETA BIONICS INC (BBNX:NASDAQ) since the previous trading day is 5.5281%.
What is the most recent average sentiment score for BETA BIONICS INC (BBNX:NASDAQ)?
The most recent average sentiment score for BETA BIONICS INC (BBNX:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for BETA BIONICS INC (BBNX:NASDAQ)?
The most recent sentiment for BETA BIONICS INC (BBNX:NASDAQ) is .
SEC-8K** Filing Available For BETA BIONICS INC (BBNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.